Filter Results:
(621)
Show Results For
- All HBS Web
(621)
- People (2)
- News (57)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
Show Results For
- All HBS Web
(621)
- People (2)
- News (57)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
- 12 Sep 2006
- First Look
First Look: September 12, 2006
alliance contracts, all of which concern early-stage research at small, biotechnology R&D companies. Staged investment is ubiquitous, but solutions to agency problems vary. The cycle of equity participation in alliances resembles what... View Details
Keywords: Sean Silverthorne
- 01 Jun 2000
- News
Seeing the Light
Living in Los Angeles and working as a marketer for a global biotechnology firm, Jana Kirlin Brownell (MBA '83) saw her career path take an unexpected turn. More than once, her father had asked her to come home and take over the Kirlin... View Details
- 13 Feb 2023
- News
Alumnus Gift Will Nurture Basic, Therapeutic Science
been a partner of the School for over two decades, and I am delighted to continue to support the HMS community in its important work by helping to modernize these landmark facilities to keep pace with therapeutics innovation." Bertarelli is a former View Details
- 20 Jun 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program? A Q&A with Bill Anderson, Senior Lecturer on Stem Cell and Regenerative Biology
Why is Harvard launching this program now? The advances in biotechnology over the past decade have been astounding. These new innovations have led to new therapeutics that will involve social, business, and political implications.... View Details
- 01 Jun 1998
- News
Short Takes
inextricably intertwined with institutions that are inherently local," he writes. He intends to test his findings by investigating process innovation in companies entering the semiconductor industry from Europe and Asia. He also plans to conduct a similar study of... View Details
Keywords: Orna Feldman and Caroline Chauncey
- 07 Dec 2015
- Research & Ideas
The Rise of Personalized Entrepreneurial Finance and Other VC Trends
flow in terms of what areas are hot or not. Biotechnology was very hot in the 80s and 90s, and then there was a long profound downturn. In the last 18 months it’s becoming really hot again with bioinformatics, which combines information... View Details
- 01 Dec 2017
- News
Removing Barriers
people from different parts of the world, she notes, is extremely valuable. Prior to coming to HBS, Anita earned a degree in biotechnology and biochemical engineering from the Indian Institute of Technology Kharagpur and then worked in... View Details
- 01 Dec 2006
- News
Faculty Books
reveal the mechanisms of advancement and speculate on what this means for the future of leadership selection and development. Science Business by Gary P. Pisano (HBS Press) Why has the biotechnology industry failed to perform to... View Details
- 03 Feb 2009
- First Look
First Look: February 3, 2009
Contractibility and Contract Design in Strategic Alliances Authors: Josh Lerner and Ulrike Malmendier Publication: American Economic Review (forthcoming) Abstract We analyze how variations in contractibility affect the design of contracts in the context of View Details
Keywords: Martha Lagace
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
Keywords: Anne Kavanagh
- 09 Sep 2010
- Working Paper Summaries
Boundary Spanning in a For-Profit Research Lab: An Exploration of the Interface Between Commerce and Academe
- 18 Feb 2016
- Blog Post
Honing an Interest in Healthcare at HBS
few other operations and finance courses. My only healthcare work was an independent study that extended some interesting research on cancer treatment access with an HBS professor, and helping another professor write a biotechnology case.... View Details
- 01 Feb 1999
- News
Classmates Rally to Help Family Stricken with Rare Disease
scientists and researchers, in conjunction with several biotechnology companies, including Genzyme Corp., are now ready to test on humans an enzyme replacement therapy that has been successful in reversing the disease in laboratory... View Details
- 11 Jun 2020
- In Practice
Are Digital Organizations Better at Overcoming COVID?
chains and people analytics to artificial intelligence-based models and automated biotechnology research, organizations further along the digital curve are responding differently than those still wondering how to evolve. The digital... View Details
Keywords: by Danielle Kost
- 01 Mar 2004
- News
The Business of Babies
surrogate mother have the right to change her mind and keep the baby she’s carrying?) and the political climate becomes more accepting of the role science can play in creation (with cloning the most radical example), the market cannot thrive. “If advances in View Details
- March 2023
- Case
Moderna
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19.... View Details
- February 1986 (Revised November 1992)
- Case
Novo Industri A/S--1981
By: W. Carl Kester and Glynn Ferguson
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of... View Details
Keywords: Capital Markets; Cost of Capital; Bonds; Stock Shares; Financing and Loans; Globalization; Biotechnology Industry; Biotechnology Industry; Denmark; United States
Kester, W. Carl, and Glynn Ferguson. "Novo Industri A/S--1981." Harvard Business School Case 286-084, February 1986. (Revised November 1992.)
- March 2022
- Teaching Note
Digital Manufacturing at Amgen
By: Shane Greenstein, Kyle R. Myers and Sarah Mehta
This teaching note provides guidance for instructors teaching “Digital Manufacturing at Amgen,” case no. 621-008. View Details
Keywords: Change; Change Management; Decision Making; Cost vs Benefits; Decisions; Information Technology; Analytics and Data Science; Innovation and Invention; Innovation and Management; Innovation Leadership; Innovation Strategy; Technological Innovation; Jobs and Positions; Knowledge; Leadership; Organizational Culture; Science; Strategy; Technology Adoption; Biotechnology Industry; Biotechnology Industry; United States; California; Puerto Rico; Rhode Island
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
- October 2019 (Revised April 2020)
- Background Note
Note on Funding Deep Tech Startups
By: Karim Lakhani, Peter Barrett and Noubar Afeyan
This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along... View Details
Keywords: Entrepreneurship; Energy; Venture Capital; Corporate Finance; Initial Public Offering; Investment; Health Testing and Trials; Innovation and Invention; Technological Innovation; Intellectual Property; Product Design; Product Development; Information Technology; Research and Development; Risk and Uncertainty; Biotechnology Industry; Biotechnology Industry; United States; North America; Europe; Asia
Lakhani, Karim, Peter Barrett, and Noubar Afeyan. "Note on Funding Deep Tech Startups." Harvard Business School Background Note 620-029, October 2019. (Revised April 2020.)